Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A retrospective cohort study with propensity score matching showing a clear association between antibiotic exposure and worse survival in EGFR-mutated NSCLC, but limited by single-centre design, modest sample size, and observational methodology that cannot establish causation.
Early-stage preclinical and patient-derived organoid study of a novel nanoplatform with promising mechanistic data but no clinical trial evidence and reliance on mouse models for efficacy claims.
A single-centre preclinical study in a murine TBI model demonstrating efficacy of an engineered cell-biomaterial platform on multiple endpoints including lesion volume, edema, and functional recovery, but lacking human translation, replication, or direct comparator arm.